碳青霉烯类耐药肠杆菌科细菌去定植策略研究现状

doi:10.3969/j.issn.1673-8640.2020.10.003

检验医学 ›› 2020, Vol. 35 ›› Issue (10): 974-978.DOI: 10.3969/j.issn.1673-8640.2020.10.003

• 碳青霉烯类耐药肠杆菌科细菌临床检测与治疗方案的发展及应用专题 • 上一篇下一篇

碳青霉烯类耐药肠杆菌科细菌去定植策略研究现状

邹成韵¹, 杨红梅¹, 王海英²

1.上海中医药大学,上海 201203
2.上海中医药大学附属岳阳中西医结合医院检验科,上海 200437

收稿日期:2019-03-10 出版日期:2020-10-30 发布日期:2020-11-12
作者简介:null
作者简介:邹成韵,女,1997年生,学士,主要从事细菌耐药研究。
基金资助:
上海中医药大学研究生创新培养专项（Y201942）

Research status of decolonization strategy of carbapenem-resistant Enterobacteriaceae

ZOU Chengyun¹, YANG Hongmei¹, WANG Haiying²

1. Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
2. Department of Clinical Laboratory,Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200437,China

Received:2019-03-10 Online:2020-10-30 Published:2020-11-12

摘要/Abstract

摘要：

目前,多药耐药细菌尤其是碳青霉烯类耐药肠杆菌科细菌（CRE）感染的治疗选择有限,而且往往效果较差。CRE定植会增加患者感染CRE的风险,临床死亡率也随之上升。文章概括了CRE的流行病学特点、定植的危害及现有防控措施,主要探讨了预防CRE定植进展的策略,包括选择性消化道净化（SDD）与最近备受关注的粪菌移植（FMT）技术的可行性和有效性,列举了2种去定植手段的优缺点,及未来需要集中解决的问题。尽管FMT去定植有效的研究证据还很缺乏,但依旧不失为CRE去定植的可靠选择。

关键词: 碳青霉烯类耐药肠杆菌科细菌, 去定植, 选择性消化道净化, 粪菌移植

Abstract:

The treatment options of multi-drug resistance bacterial infection are limited,and are often inefficient,especially for carbapenem-resistant Enterobacteriaceae（CRE）. The colonization of CRE will increase the risk of CRE infection,and the clinical mortality will increase. This review summarizes the epidemiological characteristics of CRE,the hazard of colonization and the existing prevention and control measures,which discusses the feasibility and effectiveness of 2 decolonization strategies,including selective digestive decontamination（SDD） and fecal bacterium transplantation（FMT）,which have attracted international attention recently. This review also enumerates the advantages and disadvantages of the 2 methods of decolonization and the problems that need to be solved in the future. Although there is little research evidence on the effectiveness of FMT to decolonize CRE,it is none the less a reliable choice for CRE decolonization.

Key words: Carbapene resistant Enterobacteriaceae, Decolonization, Selective digestive decontamination, Fecal bacterium transplantation

中图分类号:

R446.5

邹成韵, 杨红梅, 王海英. 碳青霉烯类耐药肠杆菌科细菌去定植策略研究现状[J]. 检验医学, 2020, 35(10): 974-978.

ZOU Chengyun, YANG Hongmei, WANG Haiying. Research status of decolonization strategy of carbapenem-resistant Enterobacteriaceae[J]. Laboratory Medicine, 2020, 35(10): 974-978.

参考文献 34

[1]	O' NEILL J. Review on antimicrobial resistance. Tackling drug resistant infections globally[ EB/OL]. (2016-05-19)[2018-08-08]. .
[2]	TEMKIN E,ADLER A,LERNER A,et al.Carbapenem-resistant Enterobacteriaceae:biology,epidemiology,and management[J]. Ann N Y Acad Sci,2014,1323:22-42.
[3]	胡付品,郭燕,朱德妹,等. 2017年CHINET中国细菌耐药性监测[J]. 中国感染与化疗杂志,2018,18(3):241-251.
[4]	CANTÓN R,AKÓVA M,CARMELI Y,et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe[J]. Clin Microbiol Infect,2012,18(5):413-431.
[5]	NOURIAN A,KARGAR M.Treatment of nosocomial infections in intensive care unit with colistin and polymyxin B[J]. Int J Clin Pharm,2019,41(6):1398-1399.
[6]	TISCHENDORF J,DE AVILA R A,SAFDAR N. Risk of infection following colonization with carbapenem-resistant Enterobactericeae:a systematic review[J]. Am J Infect Control,2016,44(5):539-543.
[7]	PAPP-WALLACE K M,ENDIMIANI A,TARACILA M A,et al. Carbapenems:past,present,and future[J]. Antimicrob Agents Chemother,2011,55(11):4943-4960.
[8]	李维特,张捷. 耐碳青霉烯肠杆菌科细菌耐药机制的研究进展[J]. 中华医院感染学杂志,2017,27(3):714-716.
[9]	MITTAL G,GAIND R,KUMAR D,et al.Risk factors for fecal carriage of carbapenemase producing Enterobacteriaceae among intensive care unit patients from a tertiary care center in India[J]. BMC Microbiol,2016,16(1):138.
[10]	MARTIN R M,BACHMAN M A.Colonization,infection,and the accessory genome of Klebsiella pneumoniae[J]. Front Cell Infect Microbiol,2018,8:4.
[11]	MCCONVILLE T H,SULLIVAN S B,GOMEZ-SIMMONDS A,et al.Carbapenem-resistant Enterobacteriaceae colonization(CRE) and subsequent risk of infection and 90-day mortality in critically ill patients,an observational study[J]. PLoS One,2017,12(10):e0186195.
[12]	SCHECHNER V,KOTLOVSKY T,KAZMA M,et al.Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae:who is prone to become clinically infected?[J]. Clin Microbiol Infect,2013,19(5):451-456.
[13]	PREDIC M,DELANO J P,TREMBLAY E,et al.Evaluation of patient risk factors for infection with carbapenem-resistant Enterobacteriaceae[J]. Am J Infect Control,2020,48(9):1028-1031.
[14]	VAN DER WAAY D. Colonization resistance of the gastrointestinal tract;new ways for infection prevention in hospitals[J]. Ned Tijdschr Geneeskd,1979,123(8):273-276.
[15]	SILVESTRI L,DE LA CAL M A,VAN SAENE H K. Selective decontamination of the digestive tract:the mechanism of action is control of gut overgrowth[J]. Intensive Care Med,2012,38(11):1738-1750.
[16]	ZUCKERMAN T,BENYAMINI N,SPRECHER H,et al.SCT in patients with carbapenem resistant Klebsiella pneumoniae:a single center experience with oral gentamicin for the eradication of carrier state[J]. Bone Marrow Transplant,2011,46(9):1226-1230.
[17]	OREN I,SPRECHER H,FINKELSTEIN R,et al.Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment:a prospective controlled trial[J]. Am J Infect Control,2013,41(12):1167-1172.
[18]	MACHUCA I,GUTIÉRREZ-GUTIÉRREZ B,PÉREZ CORTÉS S,et al. Oral decontamination with aminoglycosides is associated with lower risk of mortality and infections in high-risk patients colonized with colistin-resistant,KPC-producing Klebsiella pneumoniae[J]. J Antimicrob Chemother,2016,71(11):3242-3249.
[19]	FRANCIS J J,DUNCAN E M,PRIOR M E,et al.Comparison of four methods for assessing the importance of attitudinal beliefs:an international Delphi study in intensive care settings[J]. Br J Health Psychol,2014,19(2):274-291.
[20]	LÜBBERT C,FAUCHEUX S,BECKER-RUX D,et al. Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae:a single-centre experience[J]. Int J Antimicrob Agents,2013,42(6):565-570.
[21]	梁琦强,黄曼. 选择性消化道去污染新进展[J]. 中国感染控制杂志,2018,17(12):1111-1116.
[22]	VAN DER WAAIJ D,BERGHUIS-DE VRIES J M,LEKKERKERK LEKKERKERK-V. Colonization resistance of the digestive tract in conventional and antibiotic-treated mice[J]. J Hyg(Lond),1971,69(3):405-411.
[23]	KAMADA N,CHEN G Y,INOHARA N,et al.Control of pathogens and pathobionts by the gut microbiota[J]. Nat Immunol,2013,14(7):685-690.
[24]	GOUGH E,SHAIKH H,MANGES A R.Systematic review of intestinal microbiota transplantation(fecal bacteriotherapy) for recurrent Clostridium difficile infection[J]. Clin Infect Dis,2011,53(10):994-1002.
[25]	BRANDT L J,BORODY T J,CAMPBELL J.Endoscopic fecal microbiota transplantation:"first-line" treatment for severe Clostridium difficile infection?[J]. J Clin Gastroenterol,2011,45(8):655-657.
[26]	TAVOUKJIAN V.Faecal microbiota transplantation for the decolonization of antibiotic-resistant bacteria in the gut:a systematic review and meta-analysis[J]. J Hosp Infect,2019,102(2):174-188.
[27]	CRUM-CIANFLONE N F,SULLIVAN E,BALLON-LANDA G. Fecal microbiota transplantation and successful resolution of multidrug-resistant-organism colonization[J]. J Clin Microbiol,2015,53(6):1986-1989.
[28]	TAUR Y,PAMER E G.The intestinal microbiota and susceptibility to infection in immunocompromised patients[J]. Curr Opin Infect Dis,2013,26(4):332-337.
[29]	HUTTNER B D,DE LASTOURS V,WASSENBERG M,et al.A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae:a randomized clinical trial[J]. Clin Microbiol Infect,2019,25(7):830-838.
[30]	SAÏDANI N,LAGIER J C,CASSIR N,et al. Faecal microbiota transplantation shortens the colonisation period and allows re-entry of patients carrying carbapenamase-producing bacteria into medical care facilities[J]. Int J Antimicrob Agents,2019,53(4):355-361.
[31]	BRANDT L J,ARONIADIS O C.An overview of fecal microbiota transplantation:techniques,indications,and outcomes[J]. Gastrointest Endosc,2013,78(2):240-249.
[32]	HUI W,LI T,LIU W,et al.Fecal microbiota transplantation for treatment of recurrent C. difficile infection:an updated randomized controlled trial meta-analysis[J]. PLoS One,2019,14(1):e0210016.
[33]	WOODWORTH M H,CARPENTIERI C,SITCHENKO K L,et al.Challenges in fecal donor selection and screening for fecal microbiota transplantation:a review[J]. Gut Microbes,2017,8(3):225-237.
[34]	KELLY C R,KAHN S,KASHYAP P,et al.Update on fecal microbiota transplantation 2015:indications,methodologies,mechanisms,and outlook[J]. Gastroenterology,2015,149(1):223-237.

碳青霉烯类耐药肠杆菌科细菌去定植策略研究现状

Research status of decolonization strategy of carbapenem-resistant Enterobacteriaceae

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 34

相关文章 7

编辑推荐

Metrics

[1]	徐琪, 潘芬, 孙燕, 石迎迎, 于方圆, 张泓. 肠道定植CRE筛查技术方法学评价[J]. 检验医学, 2022, 37(8): 761-765.
[2]	孙英, 李轶, 闫文娟, 荆楠, 马冰. 河南地区少见CRE耐药性分析及碳青霉烯酶初筛实验的临床应用[J]. 检验医学, 2022, 37(2): 146-149.
[3]	尹娟, 王莹超, 眭阳, 江春, 时蕴琦, 朱超望. mCIM与eCIM在产碳青霉烯酶肠杆菌科细菌表型筛查中的价值[J]. 检验医学, 2021, 36(2): 177-180.
[4]	杨红梅, 陶建敏, 魏甜, 王蒋君, 毛嘉宏, 王海英. 2015—2019年上海某中西医结合医院住院患者碳青霉烯类耐药肠杆菌科细菌耐药性分析[J]. 检验医学, 2021, 36(1): 87-91.
[5]	李世荣, 林怡菁, 蒋晓飞, 关明. 双浓度联合改良碳青霉烯灭活试验筛查CRE的临床应用价值[J]. 检验医学, 2020, 35(10): 979-982.
[6]	唐克文, 李从荣, 郭静. CRE耐药性分析及eCIM联合mCIM的临床应用[J]. 检验医学, 2019, 34(9): 800-803.
[7]	唐吉斌, 胡志军, 张盛, 焦瑞宝. 铜陵市2014年细菌耐药性监测分析[J]. 检验医学, 2015, 30(8): 798-803.